VITARAN Launches First CE Marked Polynucleotide

Available exclusively through Fox Pharma, the latest aesthetic innovation of 2024, VITARAN harnesses the power of trout DNA for a remarkable advancement in skin rejuvenation.

Fox Pharma, renowned for developing and sourcing the highest quality emerging products in the aesthetics industry, is thrilled to introduce the highly anticipated breakthrough in polynucleotide innovation, the newest addition to its carefully curated line-up. VITARAN is the world’s first-ever 100% quality-controlled, CE- marked polynucleotide injectable which achieves transformative outcomes marking the beginning of a new era of skin rejuvenation.

With polynucleotides earning widespread acclaim amidst the industry for their regenerative efficiency and versatility, VITARAN boasts extraordinary capabilities and yields impressive results. Having earned the CE mark, signifying compliance with rigorous EU safety, health, and environmental protection standards, VITARAN maintains the highest assurance of patient safety and treatment efficacy.

Derived from 100% purified fragments of trout DNA, VITARAN is an effective injectable bio- revitalising treatment known for its exceptional anti-inflammatory properties. It aids in skin rejuvenation, repair and regeneration at a cellular level, providing a non-invasive solution to a broad scope of skin concerns.

It has the ability to address fine lines and wrinkles, dull complexion, sagging skin, eye bags, stretch marks, scarring and pigmentation, whilst enhancing overall skin firmness, tone, and texture.

Central to VITARAN's efficacy is its unique formulation of polynucleotides, which consists of filtered, ultra-purified, and sterilised DNA fragments sourced from trout. Famously recognised within the industry as the ‘youth elixir’, polynucleotides are known for their bio-stimulating abilities that facilitate cellular renewal, restore the skin's natural barrier and effectively combat signs of ageing.

As skin ages, it loses elasticity and plumpness due to decreased collagen and elastin production. This leads to the gradual formation of wrinkles, fine lines and dull, sagging skin. Additionally, factors such as sun exposure, pollution and lifestyle choices can accelerate this process over time by causing damage to the skin's structure and weakening its ability to regenerate the vital components that maintain its youth and resilience.

VITARAN I is available in two formulations, VITARAN I and VITARAN II, each tailored for specific treatment areas VITARAN I is indicated for the improvement of periocular wrinkles, notably the fine lines, wrinkles and sagging skin around the delicate under-eye area. VITARAN II has been formulated for use on the face, neck, hands and décolleté to restore skin’s firmness, elasticity and radiance.

VITARAN is exceptionally versatile and can be used across multiple areas of the face and alongside other injectables including HA skin boosters, for example, the game- changing skin booster Seventy Hyal 2000. Its progressive and prolonged results make VITARAN ideal for those wanting to address early signs of ageing. Unlike other injectables, such as dermal fillers that provide instant volume, polynucleotides focus on gradually restoring and enhancing the skin's condition from within over time.

With results backed by clinical trials, studies have shown that 83% of patients noticed an improvement in their skin just 4 weeks after beginning VITARAN treatment. Furthermore, 72% noticed an improvement in crow’s feet after only 2 weeks.

Combined with a healthy lifestyle and advised aftercare to optimise outcomes, VITARAN offers a natural solution to restore skin and helps to prolong skin health and vitality. Optimal results are typically seen three or more months after the recommended course of treatment, which consists of two to three sessions, three to four weeks apart.

To learn more about VITARAN visit Fox Pharma.